A detailed history of Advisor Group Holdings, Inc. transactions in Chroma Dex Corp. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 17,926 shares of CDXC stock, worth $98,413. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,926
Previous 1,654 983.8%
Holding current value
$98,413
Previous $4,000 1525.0%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$2.51 - $3.8 $40,842 - $61,833
16,272 Added 983.8%
17,926 $65,000
Q2 2024

Aug 13, 2024

SELL
$2.44 - $4.32 $6,100 - $10,800
-2,500 Reduced 60.18%
1,654 $4,000
Q1 2024

May 10, 2024

BUY
$1.36 - $3.84 $5,440 - $15,360
4,000 Added 2597.4%
4,154 $14,000
Q1 2022

May 04, 2022

SELL
$2.02 - $3.92 $15,313 - $29,717
-7,581 Reduced 98.01%
154 $0
Q3 2021

Nov 05, 2021

BUY
$6.05 - $10.41 $45,865 - $78,918
7,581 Added 4922.73%
7,735 $49,000
Q1 2021

May 13, 2021

SELL
$4.59 - $18.74 $207,284 - $846,298
-45,160 Reduced 99.66%
154 $1,000
Q4 2020

Feb 10, 2021

BUY
$3.93 - $5.5 $3,603 - $5,043
917 Added 2.07%
45,314 $217,000
Q3 2020

Nov 12, 2020

BUY
$4.01 - $5.56 $178,031 - $246,847
44,397 New
44,397 $178,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $375M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.